Evidence map›Paper›PMID 42303279›Full record

ReviewThe journal of obstetrics and gynaecology research2026

Immunomodulatory Role of Natural Progesterone in Pregnancy: A Review.

Prakash Mehta, Hemant Deshpande, Anjali Deshpande, Reshma Quadros, Shruti Dharmadhikari, Chintan Khandhedia, Gaurav Puppalwar, Amey Mane, Suyog Mehta

Abstract readReview
In one paragraph

Review in The journal of obstetrics and gynaecology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Prakash MehtaDepartment of Obstetrics and Gynecology, Bhagwan Mahaveer Jain Hospital, Bengaluru, Karnataka, India.
Hemant DeshpandeDepartment of Obstetrics and Gynecology, Dr. D. Y. Patil Medical College and Hospital, Pimpri-Chinchwad, Maharashtra, India.
Anjali DeshpandeDepartment of Obstetrics and Gynecology, Dr. D. Y. Patil Medical College and Hospital, Pimpri-Chinchwad, Maharashtra, India.
Reshma QuadrosDepartment of Medical Affairs and Clinical Research, Sun Pharmaceutical Industries Ltd., Mumbai, Maharashtra, India.ORCID https://orcid.org/0009-0000-1765-3583
Shruti DharmadhikariDepartment of Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Mumbai, Maharashtra, India.
Chintan KhandhediaDepartment of Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Mumbai, Maharashtra, India.
Gaurav PuppalwarDepartment of Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Mumbai, Maharashtra, India.
Amey ManeDepartment of Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Mumbai, Maharashtra, India.
Suyog MehtaDepartment of Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Mumbai, Maharashtra, India.

Funding

Sun Pharma, India
6 · The paper itself

Abstract

aimPregnancy complications such as miscarriage, preterm birth (PTB), and luteal phase defects (LPD) are significant reproductive health issues globally, with both physical and psychological implications. This review aims to examine the role of natural progesterone in pregnancy-related disorders, specifically threatened and recurrent miscarriage, PTB, and LPD. Additionally, it examines how natural progesterone's immune-modulating actions, including both direct and indirect involvement, contribute to maintaining pregnancy.

methodsThis narrative review was conducted using PubMed, Google Scholar, and reference screening to identify English-language studies examining the role of natural progesterone in miscarriage, PTB, and LPD. Emphasis was placed on progesterone's immunomodulatory actions, including cytokine regulation and the activity of the progesterone-induced blocking factor (PIBF), and their relevance to pregnancy maintenance.

resultsNatural progesterone demonstrates clinical benefit in managing threatened miscarriage, recurrent pregnancy loss, preterm labor, and LPD. Evidence shows that it is well-tolerated with manageable side effects, reducing miscarriage rates, preventing PTB, and improving LPD outcomes through its effects on the maternal-fetal interface. This review also highlights progesterone's dual immunomodulatory action, direct cytokine regulation, and indirect influence via PIBF, which together contribute to improved pregnancy maintenance and outcomes.

conclusionNatural progesterone supports pregnancy by preventing miscarriages, preterm labor, and LPD through its direct and indirect immunomodulatory mechanisms. Clinically, it is well-tolerated with no serious or unexpected adverse events. However, gaps remain in fully understanding its effectiveness, emphasizing the need for further research.

Indexed as

Abortion, HabitualImmunologic FactorsImmunomodulating AgentsPregnancy ComplicationsPremature BirthProgesteroneAbortion, ThreatenedFemaleHumansPregnancySuppressor Factors, ImmunologicImmunologic FactorsImmunomodulating AgentsProgesteroneSuppressor Factors, Immunologicanti‐inflammatory cytokinesnatural progesteronepregnancyprogesterone‐induced blocking factorpro‐inflammatory cytokines

Identifiers

PMID42303279
PMCPMC13271834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.